EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pfizer's enterprise value is $201,927 Mil.
Pfizer's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $58,497 Mil. Therefore, Pfizer's EV-to-Revenue for today is 3.45.
The historical rank and industry rank for Pfizer's EV-to-Revenue or its related term are showing as below:
PFE'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.38 Med: 4.23 Max: 8.82
Current: 3.45
During the past 13 years, the highest EV-to-Revenue of Pfizer was 8.82. The lowest was 2.38. And the median was 4.23.
PFE's EV-to-Revenue is ranked worse than 67.22% of 1025
companies
in the Drug Manufacturers industry
Industry Median: 2.33
vs PFE: 3.45
As of today (2024-04-19), Pfizer's stock price is $25.55.
Pfizer's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $10.29. Therefore, Pfizer's PS Ratio for today is 2.48.
Pfizer EV-to-Revenue Historical Data
The historical data trend for Pfizer's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Pfizer Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-Revenue
6.04
5.55
4.16
2.99
3.78
Pfizer Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-Revenue
2.99
2.64
2.92
3.02
3.78
Competitive Comparison
For the Drug Manufacturers - General subindustry, Pfizer's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pfizer EV-to-Revenue Distribution
For the Drug Manufacturers industry and Healthcare sector, Pfizer's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Pfizer's EV-to-Revenue falls into.
Pfizer's current Enterprise Value is $201,927 Mil.
Pfizer's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $58,497 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pfizer's share price for today is $25.55.
Pfizer's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pfizer EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Pfizer's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PFE has been successfully added to your 